A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Sanofi to conduct Phase 3 clinical trial to evaluate subcutaneous vs intravenous administration of Isatuximab with Pomalidomide and Dexamethasone in adults with relapsed or refractory multiple myeloma; recruitment has not yet started
Published:
June 22, 2022
by Immunotherapy Daily
|
Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults
Published:
June 10, 2022
by CE Noticias Financieras (Latin America)
|
Gerresheimer signs agreement with drug development firm ISR for large-scale production of IcoOne nasal inhaler for ISR’s Phase 3 study of its dry powder COVID-19 vaccine; Gerresheimer has annual production capacity of more than 100 million inhalers
Published:
June 02, 2022
by Gerresheimer AG
|
Pfizer partners with Northern Light Health in Brewer, Maine, to conduct third phase of Lyme disease vaccine clinical trial involving about 100 people, with registration starting in July; Maine has highest rate of Lyme disease infections in US
Published:
June 02, 2022
by Associated Press
|
Janssen to conduct Phase 3 trial to study injectable Lazertinib with subcutaneous amivantamab to treat egfr-mutated advanced, metastatic non-small cell lung cancer; drug to be administered after patient progresses on Osimertinib, chemotherapy
Published:
June 01, 2022
by Contify Life Science News
|
Ask us about our R&D/Patents market view
Trending Chart
Interactive chart with headline count